Core Insights - Resmed Inc. reported adjusted earnings per share (EPS) of $2.55 for Q1 fiscal 2026, reflecting a year-over-year increase of 15.9% and surpassing the Zacks Consensus Estimate by 2.41% [1] - The company's total revenue for the quarter was $1.34 billion, representing a 9.1% increase year over year, also exceeding the Zacks Consensus Estimate by 0.94% [2] Revenue Breakdown - The Sleep and Breathing Health segment generated revenues of $1.17 billion, up 9.5% year over year, exceeding projections of $1.15 billion [4] - Device revenues within this segment reached $680.3 million, an increase of 8.7%, with notable growth of 8% in the U.S., Canada, and Latin America, and 11% in Europe, Asia, and other markets [4] - Revenues from masks and other products amounted to $489.1 million, up 10.7%, with a 12% increase in the U.S., Canada, and Latin America [5] - The Residential Care Software segment saw revenues grow 5.9% year over year to $166.1 million, slightly below the forecast of $167.6 million [6] Margin Performance - Adjusted gross profit rose 14.3% to $828.7 million, with an adjusted gross margin of 62%, reflecting an expansion of 285 basis points [7] - Adjusted operating income for the quarter was $482.1 million, up 18.6% year over year, with an adjusted operating margin of 36.1%, an increase of 291 basis points [10] Financial Position - At the end of Q1 fiscal 2026, Resmed had cash and cash equivalents of $1.38 billion, up from $1.21 billion at the end of fiscal 2025 [11] - Total debt stood at $668.6 million, a slight increase from $668.3 million at the end of fiscal 2025 [11] - The company generated cumulative net cash from operating activities of $457.3 million, compared to $325.5 million in the previous year [11] - Resmed paid out $88 million in dividends and repurchased 523,000 shares for $150 million during the quarter [12] Strategic Outlook - The company is focused on operational excellence and strategic investments in innovation to achieve sustainable and profitable growth as it progresses through fiscal year 2026 [13]